Publs. oficiales Cerenis Therapeutics LIQUIDNET SYSTEMS

Acciones

Precio de cierre LIQUIDNET SYSTEMS Otros sitios de cotización			Varia. Cinco días.	Varia. 1 de enero.
- ^EUR	-.--%		-.--%	-.--%

11/03	ABIONYX Pharma SA presenta los resultados del ejercicio cerrado el 31 de diciembre de 2023	CI
15/02	ABIONYX Pharma SA reconoce los resultados clínicos del estudio de fase 3 Aegis-Ii que evalúa la eficacia y seguridad de la apoA-I derivada del plasma humano de CSL Behring, CSL112	CI

Mixed general Shareholders meeting notice	12/06	CO
Monthly statement on voting rights	31/05	CO
Monthly statement on voting rights	31/05	CO
Combined general shareholders meeting	22/05	CO
1st quarter turnover	16/05	CO
1st quarter turnover	16/05	CO
Universal registration document	02/05	CO
Monthly statement on voting rights	30/04	CO
Monthly statement on voting rights	30/04	CO
Monthly statement on voting rights	31/03	CO
Monthly statement on voting rights	31/03	CO
Annual results	11/03	CO
Annual results	11/03	CO
Monthly statement on voting rights	29/02	CO
Monthly statement on voting rights	29/02	CO
Monthly statement on voting rights	31/01	CO
Changes in management and corporate officers	08/01	CO
Changes in management and corporate officers	08/01	CO
Monthly statement on voting rights	31/12	CO
Monthly statement on voting rights	31/12	CO
Monthly statement on voting rights	30/11	CO
Monthly statement on voting rights	30/11	CO
Threshold crossings	30/11	CO
3rd quarter turnover	16/11	CO
3rd quarter turnover	16/11	CO